ArticleJDS communications2026
Evaluating the use of serum total solids to predict serum immunoglobulin G in Holstein and Angus crossbred calves.
Article in JDS communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study evaluated the use of serum total solids (STS) to assess passive immunity in Holstein and Angus cross Holstein calves. The objectives of our study were to (1) determine whether STS and serum IgG differs between Holstein and Angus × Holstein (Angus X) newborn calves, (2) compare the relationship between STS and serum IgG in both breeds, and (3) determine whether the industry-recommended passive immunity STS cutpoint (>62 g/L) for predicting serum IgG concentration ≥25 g/L is appropriate for Angus X calves. This observational study was part of a wider clinical trial in which calves were randomized to colostrum IgG doses ranging from 200 to 350 g. Blood samples were taken from calves at 2 d of age, and the separated serum was tested for STS (g/L) using optical refractometry. The remaining serum was stored frozen at -20°C and tested 2 wk later for IgG concentration (g/L) using radial immunodiffusion. Multivariable linear regression models were used to compare serum IgG and STS between breeds, controlling for colostrum IgG dose and calf sex. Pearson correlation coefficient and linear regression models were used to compare correlations between serum IgG and STS by breed. Area under the curve (AUC) and diagnostic sensitivity (Se) and specificity (Sp) were used to measure the ability of STS to identify calves with serum IgG ≥25 g/L. The number of calves analyzed in the final dataset from each group were 272 Holstein and 119 Angus X. Although serum IgG was similar between breeds, Holstein calves had 3.1 g/L (95% CI: 1.7, 4.5) higher STS than Angus X calves. The AUC of STS for predicting IgG ≥25 g/L was the same for both breed groups (AUC = 0.86). A previously recommended cutpoint of 62 g/L STS had Se and Sp of 51% and 91%, respectively, when predicting serum IgG ≥25 g/L in Holsteins. We found that a STS cutpoint that was 3 g lower (59 g/L) in Angus X calves provided similar performance (Se 55%, Sp 94%). Although colostral IgG absorption is similar between breeds, the relationship between serum IgG and STS differs, likely due to Angus X calves having a lower concentration of non-IgG proteins in serum. Although we acknowledge that the sensitivity of these cutpoints is low, we believe that breed-specific thresholds may be necessary to predict a calf serum IgG ≥25 g/L for Angus X calves, compared with the >62 g/L recommendation proposed for Holsteins in the literature.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.